Congress Materials – American Thoracic Society (ATS 2026)
2026 American Thoracic Society International Conference | May 15-20 | Orlando, FL
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Cardiac magnetic resonance imaging (CMR) sub-study of UNISUS in pulmonary arterial hypertension (PAH): Characteristics of enrolled patients
Francois Haddad, MD, Neli Boyanova, MMed, MPH, Jakob A. Hauser, MD, Marius Hoeper, Prof. Dr., Marc Humbert, MD, PhD, David Kiely, MD, Hilke Kracker, PhD, Vallerie V. Mclaughlin, MD, Vivek Muthurangu, MD, Ioana Preston, MD, Lilian Sanna, BS, CH, Yuichi Tamura, MD, Anton Vonk Noordegraaf, MD
This document will be available after May 15 2026
Contemporary Hospitalization and Mortality Burden in Real-world US Pulmonary Arterial Hypertension Patients
Ashwin Ravichandran; Amélie Beaudet; David Lopez; Carolyn R. Lew; Helen Varker; Michelle Jerry; Akshay Muralidhar
This document will be available on May 15 2026
Pharmacokinetic/pharmacodynamic (PK/PD) sub-study of UNISUS in pulmonary arterial hypertension (PAH): Characteristics of enrolled patients
Ioana Preston, MD, Neli Boyanova, MMed, MPH Denes Csonka, PhD, Marc Humbert, MD, PhD, Hilke Kracker, PhD, Vallerie V. Mclaughlin, MD, Yuichi Tamura, MD, Marius Hoeper, Prof. Dr.
This document will be available on May 15 2026
UNISUS hemodynamic sub-study: Study design and patient characteristics from the first head-to-head superiority study in pulmonary arterial hypertension (PAH)
Marc Humbert, MD, PhD, Arthur Backer, MSc, Neli Boyanova, MMed, MPH, Marius Hoeper, Prof. Dr., Hilke Kracker, PhD, Gabriela Lack, PhD, Vallerie V. Mclaughlin, MD, Ioana Preston, MD, Yuichi Tamura, MD
This document will be available on May 15 2026
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.